19.09.2013 - U.S. regulators have accepted an experimental fish oil-based heart drug from AstraZeneca for review and will make a decision on whether to approve it by next May. Epanova, for...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)